In vitro diagnostic (IVD) innovation support
IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.
Get to market faster with CPI
From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.
We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.
From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.

In vitro diagnostic (IVD) innovation support
IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.
Get to market faster with CPI
From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.
We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.
From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.
In vitro diagnostic (IVD) innovation support
IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.
Get to market faster with CPI
From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.
We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.
From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.

What we offer
End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.
What we offer
End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.
What we offer
End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.
Reagent development and scale-up
Accelerate the development of your IVD tests with our reagent development, formulation and process optimisation expertise. Our state-of-the-art facilities enable the development of robust engineering biology processes that ensure your regents are ready for seamless transfer to production or manufacturing, delivering cost efficiencies and optimised yields to address critical diagnostic needs.
Reagent development and scale-up
Accelerate the development of your IVD tests with our reagent development, formulation and process optimisation expertise. Our state-of-the-art facilities enable the development of robust engineering biology processes that ensure your regents are ready for seamless transfer to production or manufacturing, delivering cost efficiencies and optimised yields to address critical diagnostic needs.
Assay formulation development
Streamline your assay development journey with our formulation capabilities. We support reagent and assay development, guiding you from proof of concept to scalable processes, enabling the creation of accurate and reliable diagnostic solutions for diverse healthcare settings, including point-of-care applications.
Assay formulation development
Streamline your assay development journey with our formulation capabilities. We support reagent and assay development, guiding you from proof of concept to scalable processes, enabling the creation of accurate and reliable diagnostic solutions for diverse healthcare settings, including point-of-care applications.
Biosensor innovation
Our team works closely with you to design, develop, and optimise biosensor technologies, ensuring they’re specific, sensitive, and tailored to meet the demands of real-world healthcare applications. Whether you’re developing diagnostic tools for point-of-care settings, wearable devices, or laboratory-based systems, we provide the expertise and infrastructure needed to translate your innovative ideas into impactful solutions for global healthcare challenges.
Biosensor innovation
Our team works closely with you to design, develop, and optimise biosensor technologies, ensuring they’re specific, sensitive, and tailored to meet the demands of real-world healthcare applications. Whether you’re developing diagnostic tools for point-of-care settings, wearable devices, or laboratory-based systems, we provide the expertise and infrastructure needed to translate your innovative ideas into impactful solutions for global healthcare challenges.
In vitro diagnostics (IVDs) applications
We support IVD development and the complex path towards user adoption.

In vitro diagnostics (IVDs) applications
We support IVD development and the complex path towards user adoption.

In vitro diagnostics (IVDs) applications
We support IVD development and the complex path towards user adoption.

How we support you
Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.
How we support you
Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.
How we support you
Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.
Demonstrate form and function
Our team of scientists and engineers can accelerate your product’s development with:
Design and development of patient-centric diagnostic solutions that are sensitive, selective, specific, reproducible and enhance usability.
Fast, cost-effective prototype development to secure early-stage funding.
Integration of innovative technologies for a competitive market advantage.
Demonstrate form and function
Our team of scientists and engineers can accelerate your product’s development with:
Design and development of patient-centric diagnostic solutions that are sensitive, selective, specific, reproducible and enhance usability.
Fast, cost-effective prototype development to secure early-stage funding.
Integration of innovative technologies for a competitive market advantage.
Prove manufacturability and scalability
Whatever your innovation, we ensure it’s both manufacturable and scalable.
We provide:
Early feasibility studies to assess the manufacturability of IVDs.
Scalable production processes to ensure market readiness.
Optimisation of manufacturing methods for high-volume, cost-effective production.
Prove manufacturability and scalability
Whatever your innovation, we ensure it’s both manufacturable and scalable.
We provide:
Early feasibility studies to assess the manufacturability of IVDs.
Scalable production processes to ensure market readiness.
Optimisation of manufacturing methods for high-volume, cost-effective production.
Assess and demonstrate commercial viability
We provide the evidence and insights needed to attract investment and partnerships.
Our expertise helps:
Discover commercial opportunities and demonstrate scalability to attract investment and licensing opportunities.
Conduct user and market research to define commercial opportunities including developing product roadmaps and strategy.
Ensure market readiness for expanding diagnostic portfolios.
Assess and demonstrate commercial viability
We provide the evidence and insights needed to attract investment and partnerships.
Our expertise helps:
Discover commercial opportunities and demonstrate scalability to attract investment and licensing opportunities.
Conduct user and market research to define commercial opportunities including developing product roadmaps and strategy.
Ensure market readiness for expanding diagnostic portfolios.
Streamline regulatory compliance
Navigating the complexities of UKCA, CE, or FDA standards is easier with CPI.
Our regulatory experts:
Align your IVD innovations with regulatory requirements from the outset giving you confidence for market adoption.
Guide you through global regulatory landscapes so you can concentrate on building your business.
Ensure compliance, reducing time-to-market and mitigating risks.
Streamline regulatory compliance
Navigating the complexities of UKCA, CE, or FDA standards is easier with CPI.
Our regulatory experts:
Align your IVD innovations with regulatory requirements from the outset giving you confidence for market adoption.
Guide you through global regulatory landscapes so you can concentrate on building your business.
Ensure compliance, reducing time-to-market and mitigating risks.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare and academia.
We facilitate:
Collaboration with trusted partners to share expertise and extend capabilities, enabling you to manage your development through a single point of contact.
Discovery and access to leading-edge technologies, supply chains, and industry networks to support your innovation and production scale-up.
Strategic partnerships for long-term growth and market adoption in the UK and overseas.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare and academia.
We facilitate:
Collaboration with trusted partners to share expertise and extend capabilities, enabling you to manage your development through a single point of contact.
Discovery and access to leading-edge technologies, supply chains, and industry networks to support your innovation and production scale-up.
Strategic partnerships for long-term growth and market adoption in the UK and overseas.
private investment unlocked
R&D projects delivered
years of experience
business collaborations
facilities
innovation assets
private investment unlocked
R&D projects delivered
years of experience
business collaborations
facilities
innovation assets
private investment unlocked
R&D projects delivered
years of experience
business collaborations
facilities
innovation assets
Trusted by leading organisations
I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

Helen McAdam
Co-Inventor and Co-Executive
CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner
CEO

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury
CEO
It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross
Founder
CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

David Lawson
Co-Founder
Trusted by leading organisations
I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

Helen McAdam
Co-Inventor and Co-Executive
CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner
CEO

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury
CEO
It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross
Founder
CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

David Lawson
Co-Founder
Trusted by leading organisations
I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

Helen McAdam
Co-Inventor and Co-Executive
CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner
CEO

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury
CEO
It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross
Founder
CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

David Lawson
Co-Founder
Why choose CPI?
Why choose CPI?
Why choose CPI?
Work with us to defer capital and workforce investments until your product or process is proven at scale.






















